In Vitro Activities of the Ketolide HMR 3647 against Recent Gram-Positive Clinical Isolates and Haemophilus influenzae
- 1 August 1998
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 42 (8) , 2138-2140
- https://doi.org/10.1128/aac.42.8.2138
Abstract
The ketolide HMR 3647 (previously RU 66647) was evaluated against 2,563 recent clinical isolates of gram-positive pathogens and 200 Haemophilus influenzae isolates. HMR 3647 was active against macrolide-resistant streptococci, including pneumococci, but was not active against macrolide- or lincosamide-resistant staphylococci. Against H. influenzae , the potency of HMR 3647 was similar to that of azithromycin.Keywords
This publication has 7 references indexed in Scilit:
- Antipneumococcal Activities of a Ketolide (HMR 3647), a Streptogramin (Quinupristin-Dalfopristin), a Macrolide (Erythromycin), and a Lincosamide (Clindamycin)Antimicrobial Agents and Chemotherapy, 1998
- Antibacterial activity of RU 64004 (HMR 3004), a novel ketolide derivative active against respiratory pathogensAntimicrobial Agents and Chemotherapy, 1997
- In vitro activity of the new ketolide HMR 3004 compared to an azalide and macrolides againstStreptococcus pneumoniae andHaemophilus influenzaeEuropean Journal of Clinical Microbiology & Infectious Diseases, 1997
- Comparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU 64004)Antimicrobial Agents and Chemotherapy, 1997
- Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from out-patients in the USA.Journal of Antimicrobial Chemotherapy, 1997
- In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteriaAntimicrobial Agents and Chemotherapy, 1997
- Antimicrobial activity of RU-66647, a new ketolideDiagnostic Microbiology and Infectious Disease, 1997